67 related articles for article (PubMed ID: 35789548)
1. Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.
Xiao W; Tang P; Sui Z; Han Y; Zhao G; Wu X; Yang Y; Zhu N; Gong L; Yu Z; Zhang H
Cancer Med; 2023 Jan; 12(2):2117-2133. PubMed ID: 35789548
[TBL] [Abstract][Full Text] [Related]
2. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
Li S; Liu Z; Chen Q; Chen Y; Ji S
Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
[TBL] [Abstract][Full Text] [Related]
3. Construction of a Novel Mitochondria-Associated Gene Model for Assessing ESCC Immune Microenvironment and Predicting Survival.
Wang X; Zhang Z; Shi Y; Zhang W; Su C; Wang D
J Microbiol Biotechnol; 2024 May; 34(5):1164-1177. PubMed ID: 38719775
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic value of anoikis-related gene score model combined with tumor microenvironment score models in esophageal squamous cell carcinoma.
Zhang M; Liang Y; Song P
J Gene Med; 2024 Jan; 26(1):e3624. PubMed ID: 38087999
[TBL] [Abstract][Full Text] [Related]
5. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy.
Li C; Song W; Zhang J; Luo Y
Front Immunol; 2023; 14():1322147. PubMed ID: 38098487
[TBL] [Abstract][Full Text] [Related]
6. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer.
Qiu C; Wang W; Xu S; Li Y; Zhu J; Zhang Y; Lei C; Li W; Li H; Li X
BMC Cancer; 2024 Apr; 24(1):402. PubMed ID: 38561760
[TBL] [Abstract][Full Text] [Related]
8. VBP1 promotes tumor proliferation as a part of the hypoxia-related signature in esophageal squamous cell carcinoma.
Miao H; Gao W; Zhong L; Li H; Chen D; Xu C; Wen Z; Chen Y
Hum Cell; 2024 May; ():. PubMed ID: 38700744
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Risk Models Using Epithelial Cells Identify β-Sitosterol as a Potential Therapeutic Target Against Esophageal Squamous Cell Carcinoma.
Zhang Z; Shang B; Mao X; Shi Y; Zhang G; Wang D
Int J Gen Med; 2024; 17():1193-1211. PubMed ID: 38559590
[TBL] [Abstract][Full Text] [Related]
10. Integrating bulk and single-cell sequencing data to construct a Scissor
Cheng M; Xiong J; Liu Q; Zhang C; Li K; Wang X; Chen S
Cancer Immunol Immunother; 2024 Apr; 73(6):97. PubMed ID: 38619620
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of prognostic and immunotherapeutic responses in esophageal squamous carcinoma based on hypoxia phenotype-related genes.
Xie K; Chen Z; Feng J; Pan L; Wang N; Luo J; Yao Y; Ma H; Feng Y; Jiang W
Front Pharmacol; 2024; 15():1344317. PubMed ID: 38515846
[TBL] [Abstract][Full Text] [Related]
12. Development of a Prognostic Model for Gastric Cancer Based on Apoptosis- and Hypoxia-Related Genes: Predictive Insights into Survival and Immune Landscape.
Zhu J; Ma Y
J Environ Pathol Toxicol Oncol; 2024; 43(3):81-93. PubMed ID: 38608147
[TBL] [Abstract][Full Text] [Related]
13. A model for predicting prognosis in patients with esophageal squamous cell carcinoma based on joint representation learning.
Yu J; Wu X; Lv M; Zhang Y; Zhang X; Li J; Zhu M; Huang J; Zhang Q
Oncol Lett; 2020 Dec; 20(6):387. PubMed ID: 33193847
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptome sequencing analysis reveals intra-tumor heterogeneity in esophageal squamous cell carcinoma.
Nie Y; Yao G; Wei Y; Wu S; Zhang W; Xu X; Li Q; Zhou F; Yang Z
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38572681
[TBL] [Abstract][Full Text] [Related]
15. Serine Protease 27, a Prognostic Biomarker in Pan-cancer and Associated with the Aggressive Progression of Breast Cancer.
Xu Y; Shen Y; Bhandari A; Hirachan S; Wang O; Xia E
Curr Med Chem; 2024; 31(15):2073-2089. PubMed ID: 37282654
[TBL] [Abstract][Full Text] [Related]
16. Predicting the Prognosis of Bladder Cancer Patients Through Integrated Multi-omics Exploration of Chemotherapy-Related Hypoxia Genes.
Shi W; Dong J; Zhong B; Hu X; Zhao C
Mol Biotechnol; 2024 May; ():. PubMed ID: 38806990
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognosis of ADAMTS18 in different tumors.
Guo W; Zhang Y
Front Oncol; 2024; 14():1347633. PubMed ID: 38482210
[TBL] [Abstract][Full Text] [Related]
18. The Role of IL-18 in P2RX7-Mediated Antitumor Immunity.
Janho Dit Hreich S; Hofman P; Vouret-Craviari V
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298187
[TBL] [Abstract][Full Text] [Related]
19. High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor metastasis and poor prognosis.
Gao Y; Guan L; Jia R; Xiao W; Han Y; Li Y; Tang P; Yu Z; Zhang H
BMC Cancer; 2023 May; 23(1):417. PubMed ID: 37158817
[TBL] [Abstract][Full Text] [Related]
20. A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma.
Guo D; Zhang X; Du X; Yao W; Shen W; Zhu S
BMC Med Genomics; 2023 Feb; 16(1):27. PubMed ID: 36803971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]